Please Upload related files below
Fill in below.
Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery - link your brokerage account with SnapTrade.
On July 15, 2025, the New York Times published an article, entitled “Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed,” discussing the state of the private rehabilitation hospital industry. In the article, the Times specifically identified Encompass as one of the for-profit rehab corporations that “have had rare but serious incident of patient harm and perform below average on two key safety measure tracked by Medicare.” The article went on to note specific examples highlighting significant patient safety concerns, medication errors, and an overall lack of oversight at Encompass’ hospitals.
Following this news, Encompass’ stock price fell by $12.39 per share to close at $ 107.28 per share.